Immunome (IMNM) Retained Earnings (2019 - 2026)
Immunome (IMNM) posted Retained Earnings of $1.4 billion for Q1 2026, up 0.6% on a QoQ basis from $1.4 billion in Q4 2025, and up 58.55% year-over-year from $864.5 million in Q1 2025.
Immunome (IMNM) Retained Earnings (2019 - 2026) Analysis & Trends
Immunome's Retained Earnings history runs 8 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- Quarterly Retained Earnings rose 58.55% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 58.55% YoY) and the FY2025 annual result came in at $1.4 billion, up 364.17% from the prior year.
- Retained Earnings was $1.4 billion for Q1 2026 at Immunome, up from $1.4 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.4 billion in Q1 2026 and bottomed at -$658.3 million in Q3 2025.
- A 5-year average of $166.6 million and a median of -$99.7 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 362.65% — and 2025, when it jumped 43504500.0%.
- Immunome's Retained Earnings stood at -$116.0 million in 2022, then tumbled by 92.07% to -$222.8 million in 2023, then sank by 131.49% to -$515.8 million in 2024, then surged by 364.17% to $1.4 billion in 2025, then rose by 0.6% to $1.4 billion in 2026.
- Business Quant data shows IMNM's Retained Earnings at $1.4 billion in Q1 2026, $1.4 billion in Q4 2025, and -$658.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | -658.30 Mn |
| Jun 30, 2025 | 870.09 Mn |
| Mar 31, 2025 | 864.53 Mn |
| Dec 31, 2024 | -515.77 Mn |
| Sep 30, 2024 | 650.35 Mn |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -352.30 Mn |
| Dec 31, 2023 | -222.81 Mn |
| Sep 30, 2023 | -130.17 Mn |
| Jun 30, 2023 | -125.83 Mn |
| Mar 31, 2023 | 134.13 Mn |
| Dec 31, 2022 | -116.00 Mn |
| Sep 30, 2022 | -108.22 Mn |
| Jun 30, 2022 | -99.68 Mn |
| Mar 31, 2022 | -90.80 Mn |
| Dec 31, 2021 | 127.29 Mn |
| Sep 30, 2021 | -71.30 Mn |
| Jun 30, 2021 | -63.53 Mn |